Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Testosterone's effects on COVID-19 are unclear and need more research.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Cepharanthine shows promise as a COVID-19 treatment.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Natural products might help treat COVID-19, but current drugs like hydroxychloroquine haven't worked.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

COVID-19 severely affects older adults with chronic heart, lung, or metabolic diseases.

Targeting endolysosomes may help treat COVID-19.

Nitric oxide may help treat COVID-19 pneumonia by fighting the virus and easing symptoms.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.

FMH foods may help manage post-acute COVID-19 symptoms safely and easily.

SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Androgens play a key role in causing alopecia by changing the hair growth cycle.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Macrophage iron release is crucial for hair growth and wound healing.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.